Practicing aggressive innovation.

Bringing high-value therapies to the patients who need them requires a keen eye for potential and a dedication to accelerating the development of late-stage assets. We have both.
We are always interested in collaborating with development, manufacturing, and commercialization partners to bring innovative products to patients living with rare diseases.

Keeping the flow going.

Alkindi® Sprinkle
Status: Commercial
Alaway® Preservative Free
Status: Commercial Marketing Partner: Bausch Health
Biorphen®
Status: Commercial Marketing Partner: Xellia Pharmaceuticals
REZIPRES® Injection
Status: Approved
EPRONTIA™ Oral Solution
Status: Approved Marketing Partner: Azurity Pharmaceuticals
Carglumic Acid Tablets
Status: Commercial
Zonisamide Oral Suspension
Status: Filed Marketing Partner: Azurity Pharmaceuticals
Dehydrated Alcohol Injection
Status: Filed
Cysteine Injection
Status: Filed
ZENEO Hydrocortisone Autoinjector
Status: Under Development
Lamotrigine Oral Suspension
Status: Filed Marketing Partner: Azurity Pharmaceuticals

Interested in a partnership?

Let’s start the conversation.